- Sample collection, involving the acquisition of biological specimens such as blood, saliva, or swabs, is a foundational step in diagnostics, disease monitoring, and clinical research, and is increasingly enhanced by automation, improved transport media, and integration with digital health systems for improved traceability and efficiency
- The rising demand for sample collection is primarily driven by the growing prevalence of infectious diseases, chronic health conditions, and the increasing emphasis on early and accurate diagnostics across healthcare systems worldwide
- North America dominated the sample collection market with the largest revenue share of 38.8% in 2024, attributed to robust healthcare infrastructure, high testing volumes, and the presence of major diagnostics companies, with the U.S. at the forefront due to rising government support for public health screening and the expansion of decentralized testing models
- Asia-Pacific is expected to be the fastest growing region in the sample collection market during the forecast period due to a rapidly expanding healthcare sector, increasing awareness of preventive diagnostics, and growing investments in laboratory infrastructure
- Blood segment dominated the sample collection market with a market share of 53.1% in 2024, driven by its widespread use in diagnostic testing for a broad range of conditions and its critical role in routine health assessments and disease monitoring
